Ann: POH: POH signs agreement with Metabolic Phar, page-5

re: Ann: POH: POH signs agreement with Metabo... My understanding of AOD9604 is that it was well tested in VITRO and also as injectable in animals, where it fell down as I said before was in VIVO where the compound was changed in the gut or rendered useless, it was as far as I know never used injectably in human trials? could be wrong, but this new partnership with Phosphagenics may just well work if it can deliver AOD9604 directly through the skin using Phosphagenics patented delivery method? I guess we will just have to wait and see!


http://www.phosphagenics.com/About_Us/Technology_and_IP.aspx
Phosphagenics’ core technology is built around the discovery and development of novel techniques for improving drug delivery. Using it's patented TPM technology, which comprises vitamin E phosphates which have been shown to enhance dermal, transdermal and oral absorption of compounds. In addition to compound delivery, TPM has a range of significant biological properties which are applicable to pharmaceutical and personal care products (including nutraceuticals and cosmeceuticals).

The technology is protected by 21 patent families, either granted/pending or submitted, covering:

The TPM manufacturing process invented and fully owned by Phosphagenics. Phosphagenics has large scale manufacturing capabilities to supply TPM globally.